2021 Q1 Form 10-Q Financial Statement

#000156459021025131 Filed on May 07, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $638.8M $450.5M
YoY Change 41.8% 206.67%
Cash & Equivalents $638.8M $450.5M
Short-Term Investments
Other Short-Term Assets $2.251M $2.142M
YoY Change 5.09% 77.46%
Inventory
Prepaid Expenses $24.53M $16.15M
Receivables $90.10M $54.10M
Other Receivables $900.0K $600.0K
Total Short-Term Assets $837.1M $561.6M
YoY Change 49.06% 141.88%
LONG-TERM ASSETS
Property, Plant & Equipment $36.35M $34.19M
YoY Change 6.32% 1.08%
Goodwill $520.1M $101.0M
YoY Change 414.79% 28.15%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $83.50M $34.20M
YoY Change 144.15% 59.81%
Total Long-Term Assets $764.8M $244.3M
YoY Change 213.06% 52.21%
TOTAL ASSETS
Total Short-Term Assets $837.1M $561.6M
Total Long-Term Assets $764.8M $244.3M
Total Assets $1.602B $805.9M
YoY Change 98.77% 105.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.40M $15.30M
YoY Change 20.26% 60.44%
Accrued Expenses $69.15M $45.19M
YoY Change 53.03% 2.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $389.5M $267.8M
YoY Change 45.44% 31.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $129.8M $61.40M
YoY Change 111.4% 3246.05%
Total Long-Term Liabilities $129.8M $61.40M
YoY Change 111.4% 3246.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $389.5M $267.8M
Total Long-Term Liabilities $129.8M $61.40M
Total Liabilities $520.4M $329.6M
YoY Change 57.89% 47.33%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.081B $476.3M
YoY Change
Total Liabilities & Shareholders Equity $1.602B $805.9M
YoY Change 98.77% 105.23%

Cashflow Statement

Concept 2021 Q1 2020 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M20D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M19D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y1M9D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0082
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0125
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3983000
CY2020Q4 avlr Receivables From Customers Allowance For Doubtful Accounts
ReceivablesFromCustomersAllowanceForDoubtfulAccounts
593000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85760000
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85760000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85058000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85058000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
9000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1640867000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1339000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-559377000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1080160000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1602333000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
153601000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
111443000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
44671000
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
34254000
CY2021Q1 us-gaap Gross Profit
GrossProfit
108930000
CY2020Q1 us-gaap Gross Profit
GrossProfit
77189000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39156000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25847000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
64304000
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
49634000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30851000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21388000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
134311000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
96869000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-25381000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-19680000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
24000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1442000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-29988000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-15283000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-390000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
625000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30378000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14658000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-29988000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
18777000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9731000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7071000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4091000
CY2021Q1 us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
345000
CY2020Q1 us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
0
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2028000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
62000
CY2021Q1 avlr Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
2175000
CY2020Q1 avlr Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
1956000
CY2021Q1 avlr Non Cash Change In Earnout Liability
NonCashChangeInEarnoutLiability
1350000
CY2020Q1 avlr Non Cash Change In Earnout Liability
NonCashChangeInEarnoutLiability
-2509000
CY2021Q1 avlr Provision For Bad Debts Expense Recovery
ProvisionForBadDebtsExpenseRecovery
582000
CY2020Q1 avlr Provision For Bad Debts Expense Recovery
ProvisionForBadDebtsExpenseRecovery
631000
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
389000
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
10000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14695000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2750000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9186000
CY2021Q1 avlr Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
-2360000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85436000
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4745000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85436000
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2020Q1 avlr Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
-2250000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-541000
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
384000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1895000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
3659000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-15634000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-18568000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
15841000
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4128000
CY2021Q1 avlr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2810000
CY2020Q1 avlr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2230000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28247000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24471000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1366000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
883000
CY2021Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2311000
CY2020Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
717000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5844000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1600000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5529000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7928000
CY2021Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
7088000
CY2020Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
5716000
CY2021Q1 avlr Payments For Acquisition Related Post Closing
PaymentsForAcquisitionRelatedPostClosing
1971000
CY2020Q1 avlr Payments For Acquisition Related Post Closing
PaymentsForAcquisitionRelatedPostClosing
0
CY2021Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
CY2020Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
3760000
CY2021Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
690000
CY2020Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
65000
CY2021Q1 avlr Net Increase Decrease In Customer Fund Obligations
NetIncreaseDecreaseInCustomerFundObligations
3598000
CY2020Q1 avlr Net Increase Decrease In Customer Fund Obligations
NetIncreaseDecreaseInCustomerFundObligations
3915000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13554000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13734000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-365000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20531000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12702000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
761844000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
491333000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
741313000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
478631000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
638794000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
450535000
CY2021Q1 us-gaap Restricted Cash
RestrictedCash
68886000
CY2020Q1 us-gaap Restricted Cash
RestrictedCash
0
CY2021Q1 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
33633000
CY2020Q1 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
28096000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
741313000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
478631000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
0
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
0
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
3108000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
3493000
CY2020Q1 avlr Stock Based Compensation Costs Capitalized To Internally Developed Software
StockBasedCompensationCostsCapitalizedToInternallyDevelopedSoftware
36000
CY2021Q1 avlr Stock Based Compensation Costs Capitalized To Internally Developed Software
StockBasedCompensationCostsCapitalizedToInternallyDevelopedSoftware
225000
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
153000
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
320000
CY2021Q1 us-gaap Business Combination Consideration Transferred Other1
BusinessCombinationConsiderationTransferredOther1
0
CY2020Q1 us-gaap Business Combination Consideration Transferred Other1
BusinessCombinationConsiderationTransferredOther1
3750000
CY2021Q1 avlr Accrued Purchase Price Related To Acquisitions
AccruedPurchasePriceRelatedToAcquisitions
178000
CY2020Q1 avlr Accrued Purchase Price Related To Acquisitions
AccruedPurchasePriceRelatedToAcquisitions
0
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1263000
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
743000
CY2021Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.54%;white-space:nowrap" valign="top"> <p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1.</span></p></td> <td valign="top"> <p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><span style="font-style:italic;">Nature of Operations </span></p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:4.54%;text-indent:-4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:2.13%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Avalara, Inc. (the “Company”) provides software solutions that help businesses of all types and sizes comply with transaction tax requirements worldwide. The Company offers a broad and growing suite of compliance solutions for transaction taxes, such as sales and use tax, value-added tax (“VAT”), fuel excise tax, beverage alcohol, cross-border taxes (including tariffs and duties), lodging tax, and communications tax. These solutions enable customers to automate the process of determining taxability, identifying applicable tax rates, determining and collecting taxes, preparing and filing returns, remitting taxes, maintaining tax records, and managing compliance documents. The Company, a Washington corporation, was originally incorporated in 1999 and is headquartered in Seattle, Washington.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:2.27%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:2.13%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has wholly owned subsidiaries outside of the U.S. in Brazil, Canada, Europe, and India, which conduct sales and operations and provide business development, software development, and support services.</p>
CY2021Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:2.13%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.67%;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior period amounts have been reclassified to conform to current period presentation.</p>
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:2.13%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:2.13%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates and judgments related to revenue are described below in the Revenue Recognition Accounting Policy. Significant estimates impacting expenses include: expected credit losses associated with the allowance for doubtful accounts; the measurement of fair values of stock-based compensation award grants; the expected payout level of performance share unit grants; the expected earnout obligations in connection with acquisitions; the expected term of the customer relationship for capitalized contract cost amortization; the valuation and useful lives of acquired intangible assets; the valuation of the fair value of reporting units for analyzing goodwill; and the capitalization and useful life of capitalized software development costs. Actual results could materially differ from those estimates.</p>
CY2021Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
1400000
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
-2500000
CY2021Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13539000
CY2021Q1 avlr Revenue Recognition Contractual Renewal Period
RevenueRecognitionContractualRenewalPeriod
P1Y
CY2021Q1 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
greater than 50%
CY2021Q1 avlr Percentage Of Likelihood Of Realization Of Tax Position Upon Ultimate Settlement Minimum
PercentageOfLikelihoodOfRealizationOfTaxPositionUponUltimateSettlementMinimum
0.50
CY2021Q1 us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
30 days
CY2021Q1 avlr Concessions And Cancellations Period Allowed For Standard Subscription Contract Prior To Adoption
ConcessionsAndCancellationsPeriodAllowedForStandardSubscriptionContractPriorToAdoption
P60D
CY2021Q1 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P6Y
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
67891000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
63772000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31544000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29059000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36347000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34713000
CY2021Q1 us-gaap Depreciation
Depreciation
2600000
CY2020Q1 us-gaap Depreciation
Depreciation
2300000
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
24528000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13968000
CY2021Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
2801000
CY2020Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
2557000
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
2251000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3573000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29580000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
20098000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7903000
CY2021Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
4919000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
111443000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10413000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
69151000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
84532000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
153601000
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
4338000
CY2021Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
9577000
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
29518000
CY2021Q1 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
1633000
CY2020Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
1563000
CY2021Q1 avlr Accrued Employee Stock Purchase Plan Contributions Current
AccruedEmployeeStockPurchasePlanContributionsCurrent
3617000
CY2020Q4 avlr Accrued Employee Stock Purchase Plan Contributions Current
AccruedEmployeeStockPurchasePlanContributionsCurrent
5927000
CY2021Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
3189000
CY2020Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
5563000
CY2021Q1 avlr Accrued Partner Commissions Current
AccruedPartnerCommissionsCurrent
9010000
CY2020Q4 avlr Accrued Partner Commissions Current
AccruedPartnerCommissionsCurrent
9173000
CY2021Q1 avlr Contract Liabilities Current
ContractLiabilitiesCurrent
12466000
CY2020Q4 avlr Contract Liabilities Current
ContractLiabilitiesCurrent
10134000
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11201000
CY2020Q4 avlr Contract Liabilities Current
ContractLiabilitiesCurrent
10134000
CY2019Q4 avlr Contract Liabilities Current
ContractLiabilitiesCurrent
5197000
CY2021Q1 avlr Contract With Customer Liabilities Transferred To Deferred Revenue
ContractWithCustomerLiabilitiesTransferredToDeferredRevenue
3866000
CY2020Q1 avlr Contract With Customer Liabilities Transferred To Deferred Revenue
ContractWithCustomerLiabilitiesTransferredToDeferredRevenue
2538000
CY2021Q1 avlr Contract With Customer Liabilities Additions
ContractWithCustomerLiabilitiesAdditions
6198000
CY2020Q1 avlr Contract With Customer Liabilities Additions
ContractWithCustomerLiabilitiesAdditions
3671000
CY2021Q1 avlr Contract Liabilities Current
ContractLiabilitiesCurrent
12466000
CY2020Q1 avlr Contract Liabilities Current
ContractLiabilitiesCurrent
6330000
CY2021Q1 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P6Y
CY2021Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2020Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2021Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2020Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
49600000
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
49000000.0
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
124370000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
49691000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
74679000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
131987000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
45474000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
86513000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4400000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1800000
CY2020Q4 us-gaap Goodwill
Goodwill
513234000
CY2021Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-431000
CY2021Q1 us-gaap Goodwill
Goodwill
520120000
CY2018Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
3
CY2021Q1 us-gaap Lease Cost
LeaseCost
3900000
CY2020Q1 us-gaap Lease Cost
LeaseCost
3800000
CY2021Q1 us-gaap Sublease Income
SubleaseIncome
400000
CY2020Q1 us-gaap Sublease Income
SubleaseIncome
400000
CY2021Q1 us-gaap Lessee Operating Lease Lease Not Yet Commenced Description
LesseeOperatingLeaseLeaseNotYetCommencedDescription
No leases commenced in the three months ended March 31, 2021
CY2021Q1 avlr Number Of Classes Of Stock
NumberOfClassesOfStock
2
CY2021Q1 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
620000000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1080160000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5529000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19047000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
7088000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-390000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-29988000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
463722000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7928000
CY2020Q1 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
3750000
CY2020Q1 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
87000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
625000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-15283000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
476294000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19047000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9749000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3537014
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
28.17
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
483577000
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
296226
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
18.67
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
6079
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
15.19
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3234709
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.07
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
337587000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2021107
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.97
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
227301000
CY2021Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
3234709
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2021107
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
41900000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
36800000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
28.99
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
306533
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1213602
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.43
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-29988000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-15283000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
77904000
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77904000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5736000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7227000

Files In Submission

Name View Source Status
0001564590-21-025131-index-headers.html Edgar Link pending
0001564590-21-025131-index.html Edgar Link pending
0001564590-21-025131.txt Edgar Link pending
0001564590-21-025131-xbrl.zip Edgar Link pending
avlr-10q_20210331.htm Edgar Link pending
avlr-10q_20210331_htm.xml Edgar Link completed
avlr-20210331.xsd Edgar Link pending
avlr-20210331_cal.xml Edgar Link unprocessable
avlr-20210331_def.xml Edgar Link unprocessable
avlr-20210331_lab.xml Edgar Link unprocessable
avlr-20210331_pre.xml Edgar Link unprocessable
avlr-ex101_103.htm Edgar Link pending
avlr-ex311_6.htm Edgar Link pending
avlr-ex312_9.htm Edgar Link pending
avlr-ex321_7.htm Edgar Link pending
avlr-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending